Merck, Simcere team up in China

Merck has inked a joint venture partnership with China's Simcere Pharmaceutical Group. In addition to vaccines, which the two companies already market together, Simcere and Merck will market and manufacture cardiovascular and metabolic drugs. The joint venture also covers some development work, though Merck's release didn't provide any details about that aspect of the deal. Report

Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.